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Nonannular binding siteThe serotonin1A receptor is an important member of the G-protein coupled receptor family, and is involved in
the generation and modulation of a variety of cognitive and behavioral functions. Solubilization of the
hippocampal serotonin1A receptor by CHAPS is accompanied by loss of cholesterol that results in a reduction
in speciﬁc agonist binding activity. Replenishment of cholesterol to solubilized membranes restores
membrane cholesterol content and signiﬁcantly recovers speciﬁc agonist binding. In order to test the
stringency of cholesterol requirement, we solubilized native hippocampal membranes followed by
replenishment with desmosterol. Desmosterol is the immediate biosynthetic precursor of cholesterol in the
Bloch pathway differing only in a double bond at the 24th position. Our results show that replenishment with
desmosterol restores ligand binding of serotonin1A receptors. This is consistent with earlier results showing
that desmosterol can replace cholesterol in a large number of cases. However, these results appear to be
contradictory to our earlier ﬁndings, performed by sterol manipulation utilizing methyl-β-cyclodextrin, in
which we observed that replacing cholesterol with desmosterol is unable to restore speciﬁc ligand binding of
the hippocampal serotonin1A receptor. We discuss the possible molecular mechanism, in terms of nonannular
lipid binding sites around the receptor, giving rise to these differences.: +91 40 2716 0311.
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Cholesterol is an essential and representative lipid in higher
eukaryotic cellular membranes and is crucial in membrane organiza-
tion, dynamics, function, and sorting [1,2]. It is often found distributed
nonrandomly in domains in biological and model membranes [3–6].
These domains (sometimes termed as ‘lipid rafts’) contribute to
variable patchiness of the membrane, and are believed to be important
since membrane sorting and trafﬁcking [7], signal transduction
processes [8], and the entry of pathogens [9] have been attributed to
these type of domains.
Cholesterol is the end product of a long, multi-step and exceedingly
ﬁne-tuned sterol biosynthetic pathway that parallels sterol evolution
[10,11]. Konrad Bloch speculated that the sterol biosynthetic pathway
parallels sterol evolution (the “Bloch hypothesis”). According to this
hypothesis, cholesterol has been selected over a very long time scale of
natural evolution for its ability to optimize certain physical properties of
eukaryotic cell membranes with regard to biological functions.
Desmosterol is the immediate precursor of cholesterol in the Bloch
pathway of cholesterol biosynthesis and differs with cholesterol only ina double bond at the 24th position in its ﬂexible alkyl side chain (see
Fig. 1). Desmosterol is converted to cholesterol in the ﬁnal step of the
Bloch pathway by the enzyme 3β-hydroxy-steroid-Δ24-reductase
(DHCR24). Interestingly, it has been previously reported that Dhcr24
gene knockout (Dhcr24−/−)mice,which contain desmosterol instead of
cholesterol, are viable and exhibit a mild phenotype [12].
The G-protein coupled receptor (GPCR) superfamily is the largest
and most diverse protein family in mammals, involved in signal
transduction across membranes [13,14]. GPCRs are prototypical
members of the family of seven transmembrane domain proteins
and include N800 members which together constitute ~5% of the
human genome [15]. GPCRs regulate physiological responses to a
diverse array of stimuli, and mediate multiple physiological processes.
For this reason, GPCRs have emerged as major targets for the
development of novel drug candidates in all clinical areas [16]. It is
estimated that up to 50% of clinically prescribed drugs act as either
agonists or antagonists of GPCRs [17]. The serotonin1A receptor is an
important member of the GPCR family and is implicated in the
generation and modulation of various cognitive, behavioral and
developmental functions [18–20]. The serotonin1A receptor agonists
and antagonists have been shown to possess potential therapeutic
effects in anxiety or stress-related disorders [18]. As a result, the
serotonin1A receptor serves as an important target in the development
of therapeutic agents for neuropsychiatric disorders such as anxiety
Fig. 1. Chemical structures of desmosterol and cholesterol. Desmosterol is the immediate
precursor of cholesterol in the Bloch pathway, one of the two routes of cholesterol
biosynthesis. It differs with cholesterol only in a double bond at the 24th position in the
ﬂexible alkyl side chain (highlighted in its chemical structure). See text for more details.
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the serotonin1A receptor, a transmembrane protein, its interaction
with the surrounding membrane lipids assumes signiﬁcance in
modulating the function of the receptor in healthy and diseased
states [20,21]. In this context, previous work from our laboratory
comprehensively demonstrated the requirement of membrane cho-
lesterol in the function of the serotonin1A receptor ([21–23]; reviewed
in [24,25]).
Lipid–protein interactions can be suitably monitored if the mem-
brane protein in question is puriﬁed. An essential criterion for
puriﬁcation of an integral membrane protein is that the protein must
be carefully removed from the native membrane and dispersed
individually in solution. This is most effectively accomplished using
amphiphilic detergents and the process is known as solubilization
[26,27]. Solubilization of membrane proteins is a process in which the
proteins and lipids, that are held together in native membranes, are
suitably dissociated in a buffered detergent solution. The controlled
dissociation of the membrane results in the formation of small protein
and lipid clusters that remain dissolved in the aqueous solution. We
earlier partially puriﬁed the hippocampal serotonin1A receptor by
solubilizing the receptor in a functionally active form [28] using CHAPS,
a mild non-denaturing and zwitterionic detergent. Solubilized mem-
branes represent serotonin1A receptor in relatively puriﬁed (enriched)
form after loss of other proteins and lipids. In the absence of puriﬁed
receptors (none of the G-protein coupled serotonin receptors has been
puriﬁed from natural sources yet), functionally active solubilized re-
ceptors represent a suitable system to monitor lipid–protein interac-
tions. Solubilization often leads to delipidation, i.e., loss of membrane
lipids. This results in considerable loss of activity of the solubilized
protein or receptor, since lipid–protein interactions play a crucial role in
maintaining the structure and function of integral membrane proteins
and receptors [29]. Interestingly, it has been previously shown that
solubilization of the serotonin1A receptor byCHAPS leads to reduction in
membrane cholesterol and ligand binding function [30,31]. We have
earlier shown that ligand binding function of the serotonin1A receptor
could be restored upon replenishment of solubilized membranes with
cholesterol [31]. In order to examine the stringency of sterol structure
necessary for ligand binding function of serotonin1A receptors, we
monitored whether desmosterol can support the ligand binding
function of the solubilized hippocampal serotonin1A receptor.
2. Materials and methods
2.1. Materials
Desmosterol, CHAPS, cholesterol, MβCD, DMPC, DPH, EDTA, EGTA,
MgCl2, MnCl2, iodoacetamide, PEG, PMSF, serotonin, sucrose, polyethy-
lenimine, sodium azide, and Tris were obtained from Sigma Chemical
Co. (St. Louis, MO). BCA reagent for protein estimation was from Pierce
(Rockford, IL). [3H]8-OH-DPAT (sp. activity 106 Ci/mmol) was pur-
chased from DuPont New England Nuclear (Boston, MA). GF/B glass
microﬁber ﬁlters were from Whatman International (Kent, U.K.). All
solvents used were of analytical grade. Precoated silica gel 60 thin layerchromatography plates were from Merck (Darmstadt, Germany). All
other chemicals used were of the highest purity available. Water was
puriﬁed through a Millipore (Bedford, MA) Milli-Q system and used
throughout. Fresh bovine brains were obtained from a local slaughter-
housewithin 10 min of death and the hippocampal regionwas carefully
dissected out. The hippocampi were immediately ﬂash frozen in liquid
nitrogen and stored at−70 °C till further use.
2.2. Methods
2.2.1. Preparation of native hippocampal membranes
Native hippocampal membranes were prepared as described
previously [32]. Bovine hippocampal tissue (~50 g) was homogenized
10% (w/v) in a polytron homogenizer in buffer A (2.5 mM Tris, 0.32 M
sucrose, 5 mMEDTA, 5 mMEGTA, 0.02% sodium azide, 0.24 mMPMSF,
10 mM iodoacetamide, pH 7.4). The homogenate was centrifuged at
900×g for 10 min at 4 °C. The resultant supernatant was ﬁltered
through four layers of cheesecloth and centrifuged at 50,000×g for
20 min at 4 °C. The pellet obtained was suspended in 10 vol. of buffer
B (50 mM Tris, 1 mM EDTA, 0.24 mM PMSF, 10 mM iodoacetamide,
pH 7.4) using a hand-held Dounce homogenizer and centrifuged at
50,000×g for 20 min at 4 °C. This procedure was repeated until the
supernatant was clear. The ﬁnal pellet (native membranes) was
suspended in a minimum volume of buffer C (50 mM Tris, pH 7.4),
homogenized using a hand-held Dounce homogenizer, ﬂash frozen in
liquid nitrogen and stored at −70 °C. Protein concentration was
assayed using the BCA reagent [33].
2.2.2. Solubilization of native membranes
Native hippocampal membranes were solubilized as described
earlier using CHAPS [28,34]. CHAPS-solubilized membrane was
precipitated using PEG in order to remove NaCl from the solubilized
extract, since agonist binding of the serotonin1A receptor is inhibited
by NaCl [32]. This procedure is also believed to remove detergent. The
PEG-precipitated CHAPS-solubilized membrane (referred to as solu-
bilized membranes in this paper) was suspended in buffer C and used
immediately either for radioligand binding assays or for sterol
replenishment.
2.2.3. Desmosterol and cholesterol replenishment of solubilized
membranes
Solubilized membranes were replenished with desmosterol or
cholesterol using water soluble desmosterol–MβCD or cholesterol–
MβCD complex. The complex was prepared by dissolving required
amounts of desmosterol or cholesterol and MβCD in a ratio of
1:10 (mol/mol) in buffer C by constant vortexing at room
temperature (~23 °C). Stock solutions (typically 2 mM desmosterol
(or cholesterol):20 mM MβCD) of this complex were freshly
prepared prior to each experiment. Desmosterol and cholesterol
replenishments were carried out at a protein concentration of
~2 mg/ml by incubating solubilized membranes with 1 mM
desmosterol (or cholesterol):10 mM MβCD complex for 30 min
in buffer C at 25 °C under constant shaking. Membranes were then
spun down at 100,000×g for 1 h at 4 °C, suspended in the same
buffer, and immediately used for radioligand binding assays.
2.2.4. Radioligand binding assays
Receptor binding assays were carried out as described earlier [22]
with somemodiﬁcations. Tubes in duplicate with ~0.5 mg protein in a
total volume of 1 ml of buffer D (50 mM Tris, 1 mM EDTA, 10 mM
MgCl2, 5 mM MnCl2, pH 7.4) were incubated with the radiolabeled
agonist [3H]8-OH-DPAT (ﬁnal concentration in assay tube being
0.29 nM) for 1 h at 25 °C. Nonspeciﬁc binding was determined by
performing the assay in the presence of 10 μM serotonin. The binding
reaction was terminated by rapid ﬁltration under vacuum in a
Millipore multiport ﬁltration apparatus through Whatman GF/B
Fig. 2. Estimation of sterol content of native and PEG-precipitated CHAPS-solubilized
hippocampal membranes (solubilized membranes, SM), and cholesterol/desmosterol-
replenished solubilized membranes. Total lipids were extracted from membranes and
sterols were separated using TLC as shown in (a). The chromatogram shows sterols
from native membranes (lane 3), solubilized membranes (lane 4), and solubilized
membranes replenished with either cholesterol (lane 5) or desmosterol (lane 6). The
arrows represent positions of cholesterol and desmosterol on the thin layer
chromatogram identiﬁed using standards in lanes 1 and 2, respectively. Cholesterol
(hatched bar), desmosterol (horizontal lined bar) and total sterol (crisscrossed bar)
were quantiﬁed by densitometric analysis of the chromatogram and are shown in (b).
Values are expressed as percentages of the cholesterol content of native membranes
without any treatment and total sterol content of membranes was obtained by the
addition of cholesterol and desmosterol contents. Data represent means±S.E. of three
independent experiments. See Materials and methods for more details.
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were presoaked in 0.15% polyethylenimine for 1 h [35]. Filters were
then washed three times with 3 ml of cold water (4 °C), dried and the
retained radioactivity was measured in a Packard Tri-Carb 1500 liquid
scintillation counter using 5 ml of scintillation ﬂuid.
2.2.5. Estimation of desmosterol and cholesterol by thin layer
chromatography
Total lipids were extracted from native and solubilized mem-
branes, and cholesterol/desmosterol-replenished solubilized mem-
branes according to Bligh and Dyer [36]. Lipid extracts were dried
under a stream of nitrogen at 45 °C. The dried extracts were then
dissolved in a mixture of chloroform/methanol (1:1, v/v). Sterol
contents of membranes under various conditions were estimated by
TLC. Precoated silica gel TLC plates were impregnated with 3% (w/v)
silver nitrate in methanol, allowed to dry brieﬂy and activated at
120 °C for 15 min. Sterols were resolved using chloroform/diethyl
ether (95:5, v/v) as the solvent system as described previously [37]. In
order to achieve maximum separation, TLC was run three times in the
same solvent and the plate was dried after each run. The separated
lipids were visualized by charring with a solution containing cupric
sulfate (10%, w/v) and phosphoric acid (8%, v/v) at 150 °C.
Desmosterol and cholesterol bands were identiﬁed with the help of
standards (Fig. 2a). TLC plates were scanned and sterol band
intensities were analyzed as described earlier [38].
2.2.6. Estimation of inorganic phosphate
The concentration of lipid phosphate was determined subsequent
to total digestion by perchloric acid [39] using Na2HPO4 as standard.
DMPC was used as an internal standard to assess lipid digestion.
Samples without perchloric acid digestion produced negligible
readings.
2.2.7. Fluorescence anisotropy measurements
Fluorescence anisotropymeasurements were carried out using the
ﬂuorescent probe 1,6-diphenyl-1,3,5-hexatriene (DPH) as described
previously [34,38]. Steady state ﬂuorescence was measured in a
Hitachi F-4010 spectroﬂuorometer using 1 cm path length quartz
cuvettes at room temperature (~23 °C). Excitation and emission
wavelengths were set at 358 and 430 nm. Excitation and emission
slits with nominal bandpasses of 1.5 and 20 nmwere used. The optical
density of the samples measured at 358 nm was 0.15±0.01. The
anisotropy values remained identical even after dilution of membrane
samples, indicating the absence of any scattering artifact [40].
Fluorescence anisotropy measurements were performed using a
Hitachi polarization accessory. Anisotropy (r) values were calculated
as described previously [37,41]. All experiments were done with
multiple sets of samples and average values of ﬂuorescence
anisotropy are shown in Fig. 4.
2.2.8. Statistical analysis
Signiﬁcance levels were estimated by Student's two-tailed unpaired
t-test using Graphpad Prism software version 4.0 (San Diego, CA).
3. Results and discussion
Effective solubilization and puriﬁcation of a membrane protein in a
functionally active form represent important steps in understanding the
structure-function relationship of a given protein [26]. However,
solubilization of a membrane protein with retention of activity poses a
formidable challenge since many detergents irreversibly denature
membrane proteins [42]. It should be mentioned here that the
conditions used by us for solubilization of the serotonin1A receptor are
ﬁne-tuned and highly optimized. For example, it is known that
treatment of membranes with high concentration of CHAPS results in
dissociation and depletion of βγ dimer of trimeric G-proteins [43–45].Use of CHAPS at high concentration may therefore be detrimental for
solubilizing G-protein coupled receptors in a functionally active form.
Keeping this in mind, we devised an efﬁcient strategy using CHAPS at a
low (pre-micellar) concentration in presence of NaCl followed by PEG
precipitation. The advantage of using low concentration of CHAPS is that
the receptor-G protein coupling remains unperturbed. In addition, PEG
precipitation helps in efﬁciently removing detergent and salt from
solubilized membranes [46–50]. Taken together, hippocampal mem-
branes solubilized this way represent one of the bestmembrane system
available for exploring lipid–protein interactions.
Solubilization of native membranes results in loss of cholesterol and
treatment with MβCD–sterol complex is an effective approach to
replenishmembranes with sterol [38]. Fig. 2a shows the chromatogram
displaying sterol contents in native (control), solubilized and solubi-
lized membranes replenished with either desmosterol or cholesterol.
Fig. 4. Effect of replenishment of cholesterol and desmosterol into solubilized
membranes on steady state ﬂuorescence anisotropy of the membrane probe DPH.
Solubilized membranes were replenished with desmosterol or cholesterol, using 1 mM
desmosterol (or cholesterol):10 mM MβCD complex. Fluorescence anisotropy mea-
surements were performed with membranes containing 50 nmol phospholipid at a
probe to phospholipid ratio of 1:100 (mol/mol) at room temperature (~23 °C). Values
represent means±S.E. of duplicate points from three independent experiments. See
Materials and methods for more details.
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reduction upon solubilization (see Fig. 2b). This is accompanied by a
corresponding reduction (~36%) in speciﬁc [3H]8-OH-DPAT binding to
the serotonin1A receptor (see Fig. 3). Subsequent treatment with
MβCD–cholesterol complex increased the cholesterol content to ~114%
of control membranes (Fig. 2b). This resulted in recovery (~99% of
nativemembranes) of speciﬁc [3H]8-OH-DPAT binding (Fig. 3). In order
to examine whether replenishment with desmosterol could restore
speciﬁc [3H]8-OH-DPAT binding, solubilized membranes were treated
with MβCD–desmosterol complex. Fig. 2b shows that the extent of
replenishment of desmosterol was comparable such that the total sterol
(cholesterol+desmosterol) content of desmosterol-replenished mem-
braneswas ~122%. The phospholipid content was found to be unaltered
under sterol replenishment conditions (see Fig. S1). Interestingly, Fig. 3
shows that speciﬁc [3H]8-OH-DPAT binding was completely restored
(to ~100% of native membranes), when replenishment was carried out
with desmosterol. These results therefore demonstrate that desmosterol
can replace cholesterol for speciﬁc ligand binding function of the
hippocampal serotonin1A receptor in solubilized membranes. These
results could have important implications in the overall context of
sterol binding sites in the serotonin1A receptor (see later).
In order to monitor the overall membrane order under these
conditions, ﬂuorescence anisotropy measurements were carried out
with the membrane probe DPH. DPH is a rod-like molecule and
partitions into the interior of the bilayer. This partitioning has
previously been shown to be independent of the phase state of the
membrane [51]. Fluorescence anisotropy is correlated to the rota-
tional diffusion of membrane embedded probes such as DPH [41],
which is sensitive to the packing of lipid acyl chains. Fig. 4 shows that
the ﬂuorescence anisotropy of DPH does not exhibit a signiﬁcant
change in solubilized and desmosterol- or cholesterol-replenished
solubilized hippocampal membranes. The relative invariance of the
ﬂuorescence anisotropy of DPH could be due to minor changes in
sterol/phospholipid ratio under these conditions [52]. This points out
that the overall membrane order during solubilization and upon sterol
replenishment remains invariant within experimental error.
The function of a growing number of GPCRs depends on
membrane cholesterol (a comprehensive list is provided in ref.
[25]). Previous work from our laboratory demonstrated the necessity
of membrane cholesterol in maintaining the ligand binding function
of the hippocampal serotonin1A receptor [22,53,54]. In this paper, we
have replaced cholesterol with desmosterol to test the stringency of
the requirement of membrane cholesterol in maintaining the functionFig. 3.Effect of replenishment ofdesmosterol or cholesterol into solubilizedmembraneson
speciﬁc binding of [3H]8-OH-DPAT to the hippocampal serotonin1A receptor. Solubilized
membranes were replenished with desmosterol or cholesterol, using 1 mM desmosterol
(or cholesterol):10 mM MβCD complex. Values are expressed as percentages of speciﬁc
binding obtained in native membranes. Data shown are means±S.E. from at least ﬁve
independent experiments. See Materials and methods for other details.of the solubilized hippocampal serotonin1A receptor. As mentioned
earlier, desmosterol differs with cholesterol only in a double bond at
the 24th position in the ﬂexible acyl side chain. Our results
demonstrate that desmosterol is capable of supporting the ligand
binding function of the solubilized serotonin1A receptor.
Previous biophysical measurements by us [55] and others [56,57]
have shown that the effects of cholesterol and desmosterol on
membrane organization and dynamics are similar. Desmosterol has
previously been shown to substitute for cholesterol in mutant mouse
L-cell ﬁbroblasts [58]. In addition, it has been shown that in absence of
cholesterol, desmosterol alone can support cell proliferation in a
murine macrophage-like cells [59]. More importantly, results from
studies using Dhcr24 gene knockout (Dhcr24−/−) mice [12] or cells
derived from them [60,61] show that desmosterol can act as a suitable
replacement for cholesterol. For example, the Dhcr24 gene knockout
mice are viable and exhibit a mild phenotype although they are
smaller in size and are sterile [12]. However, certain degree of caution
should be exercised while interpreting these results. The Dhcr24−/−
mice are not totally cholesterol-free (strictly speaking, these are low
cholesterol, high desmosterol Dhcr24−/− knockout mice) due to
availability of maternal cholesterol inmice during embryogenesis [12]
since maternal cholesterol can cross the placenta in rodents [62]. Our
results showing that desmosterol is capable of supporting the ligand
binding function of the solubilized serotonin1A receptor is in overall
agreement with the above reports.
Interestingly, we have previously shown that desmosterol is not
capable of supporting the ligand binding function of the hippocampal
serotonin1A receptor when sterol (cholesterol) depletion and replenish-
ment are carried out usingMβCD andMβCD–sterol complex, respectively
[37]. Our present results appear to be contradictory to these results.
We believe that an analysis of the reason for this apparent discrepancy
could provide novel information about the nature of cholesterol
binding sites around the serotonin1A receptor. The key difference in
these instances is the way we have carried out sterol manipulations in
the membrane. While in our earlier work, we used MβCD for such
sterol manipulations [37], we employed the strategy of solubilization
and effectively utilized the lipid loss associated with solubilization
[30,31] for achieving sterol depletion in the present work.
We recently proposed that cholesterol binding sites in GPCRs
could represent nonannular binding sites [63]. Integral membrane
proteins are surrounded by a shell or annulus of lipid molecules,
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proteins [64]. These are termed ‘annular’ lipids surrounding the
membrane protein. The annular lipids are exchangeable with bulk
lipids [65], although this exchange rate is slower compared to
exchange rate between bulk lipids. In addition to the annular lipids,
there is evidence for other lipid molecules in the immediate vicinity of
integral membrane proteins. These are termed as ‘nonannular’ lipids
(see Fig. 5a). Cholesterol has previously been proposed to be localized
in nonannular sites in Ca2+/Mg2+-ATPase [66], the nicotinic acetyl-
choline receptor [67], and anionic phospholipids have been reported
to occupy nonannular sites in the potassium channel KcsA from
Streptomyces lividans [68] and gap junction hemichannel connexin 26Fig. 5. (a) A schematic representation of a membrane embedded seven transmembrane do
lipids (shown in pink) represent the shell (or annulus) of lipid molecules around the recepto
lipids. Bulk lipids are shown in green. See text for more details. (b) A schematic represen
replenished solubilized membranes, and (iv) desmosterol-replenished solubilized membra
serotonin1A receptor (purple), other integral (light brown) and peripheral (light blue) mem
CHAPS (single tailed molecule in cyan), results in loss of phospholipids, and integral and p
Solubilization also causes loss of cholesterol bound to the serotonin1A receptor and appear
membranes with (iii) cholesterol and (iv) desmosterol (shown in orange) appears to restore
receptor. Note that the membrane components are loosely packed in the solubilized memb[69]. Nonannular sites are characterized by lack of accessibility to the
annular lipids, i.e., these sites cannot be displaced by competition with
annular lipids. Binding to the nonannular sites is considered to be
more speciﬁc compared to annular binding sites [64]. As a result,
nonannular lipid binding sites remain vacant even in the presence of
annular lipids around the protein [68]. It has been suggested that the
possible locations for the nonannular sites could be either inter or
intramolecular (interhelical) protein interfaces, characterized as deep
clefts (or cavities) on the protein surface [66,68].
Nonannular lipids are often believed to be preserved in the high
resolution crystal structure of membrane proteins, i.e., they survive the
crystallization conditions [64]. Lipid molecules resolved in highmain receptor showing various classes of lipids in the vicinity of the receptor. Annular
r. Nonannular lipids (shown in blue) are characterized by lack of accessibility to annular
tation depicting (i) native membranes, (ii) solubilized membranes, (iii) cholesterol-
nes. Native membranes in (i) show phospholipids (green), cholesterol (maroon), the
brane proteins. (ii) Solubilization of native membranes with the zwitterionic detergent
eripheral membrane proteins, leading to partial puriﬁcation of serotonin1A receptors.
s to affect the ‘nonannular’ binding sites for cholesterol. Replenishment of solubilized
nonannular lipid sites resulting in recovery of speciﬁc ligand binding to the serotonin1A
rane. See text for more details.
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to be nonannular lipids [29]. We have recently suggested, based on the
reported crystal structure of the β2-adrenergic receptor [70,71], that
cholesterol molecules located at the interhelical/interprotein regions of
the receptor could represent nonannular lipids [63]. Based on the high
degree of sequence similarity (~48%) between transmembrane regions
of the serotonin1A receptor andβ2-adrenergic receptor [72], we propose
that the cholesterol-dependent activity of the serotonin1A receptor is
partly due to the presence of tightly bound cholesterol molecules at the
nonannular site(s). In fact, we have recently reported from receptor
modeling studies that the serotonin1A receptor is more compact in the
presence of tightly bound cholesterol [72]. In addition, we have very
recently identiﬁed cholesterol recognition/interaction amino acid
consensus (CRAC) motifs in the serotonin1A receptor [73]. The CRAC
motif represents a characteristic structural feature of proteins that are
believed to result in preferential associationwith cholesterol [74,75]. As
mentioned above, it has been previously postulated that the possible
locations for the nonannular sites could be either inter or intramolecular
(interhelical) protein interfaces, characterized as deep clefts (or
cavities) on the protein surface [66,67]. Interestingly, it has been
suggested that cholesterol binding by CRACmotif is induced by a similar
cleft located at the membrane interfacial region [76]. Taken together,
nonannular cholesterol appears to be crucial for maintaining the
function of the serotonin1A receptor.
We believe that the difference in results obtained in the above two
cases lies in the ability of desmosterol to occupy nonannular sites when
added as MβCD–desmosterol complex following solubilization since
solubilization allows a more robust reorganization of membranes (see
Fig. 5b). This is because membrane lipids and proteins are loosely
packed in solubilized membranes compared to MβCD-treated native
membranes. Solubilized membranes are loose, metastable and are
composed of heterogeneous complexes of detergent, lipid and protein,
forming mixed micelles [26]. We previously attributed such loose
packing of solubilized membranes to enhanced susceptibility of the
serotonin1A receptor to ethanol [77].MβCD, on theotherhand, is known
to preferentially deplete membrane cholesterol from regions of the
membrane where cholesterol is present in relatively ﬂuid (liquid
disordered) phase and not from the ordered cholesterol-rich domains
[78–80]. Membrane reorganization as a result of such cholesterol
depletion by MβCD therefore may not be sufﬁcient (robust) to replace
the nonannular sites with desmosterol, a necessary step for recovery of
activity. Solubilization and subsequent sterol replenishment may just
allow this important step, thereby resulting in recovery of activity
(Fig. 3).
In summary, we show here that desmosterol is capable of
supporting the ligand binding function of the solubilized serotonin1A
receptor, provided sterol manipulation is carried out on solubilized
membranes. Our results are consistent with previous reports,
spanning biophysical studies using model membranes [55–57] to
animal models [12,60,61], showing that desmosterol can replace
cholesterol in a large number of cases. We further conclude that
caution should be exercised while interpreting results from sterol
replacement experiments, in view of the complexities involved.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.bbamem.2011.06.022.
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